[English] [Español]
[Turkish]
International View Help

Division of Pathology and Laboratory Medicine The Division of Pathology and Laboratory Medicine is the integral bridge between clinical care and basic science at the University of Texas M. D. Anderson Cancer Center. It plays an essential role in the institution's mission to improve patient care and eliminate cancer and allied diseases as a significant problem in Texas, the United States and the world. The Division comprises three clinical departments and one research department: Pathology, Laboratory Medicine, Hematopathology and Molecular Pathology (research). The Division and the Departments serve M. D. Anderson patients, Outreach and Physician Network patients, and clinical staff. The faculty engages in programmatic and interdisciplinary basic, clinical and translational research. The Division offers academic programs for post-residency fellowship training in oncologic pathology in Surgical Pathology, Cytopathology and in the Department of Hematopathology. Additional education programs provide training in the Allied Health fields of Medical Technology, Cytogenetics, Cytotechnology, and Histopathology. The Division occupies over 120,000 square feet in six adjoining buildings within the M. D. Anderson complex in the Texas Medical Center. It employs 75 clinical and research doctoral faculty and 25 clinical fellows. In the division, the supporting technical and clerical staff numbers 500. The clinical laboratory processes over 4 million tests per year. The faculty includes expertise across the entire spectrum of oncologic pathology, hematopathology, and laboratory medicine. Surgical Pathology is now divided into nine subspecialty groups: breast, dermatopathology, gastrointestinal, genitourinary, head and neck, neuropathology, sarcoma/unknown primary tumor, thoracic/ mediastinial, and hematopathology. Consultation on specimens from patients sent to MDACC, or second opinion cases, represent about 60% of our caseload. The review of diagnostic material obtained and evaluated elsewhere has been shown to be of significant importance both in terms of quality of care and economic benefit.